Related Experiment Video
Updated: Jul 12, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai,
Kongbo Zhu1, Shaolei Ma2, Hui Chen3
1Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
Insights
COVID-19 vaccine uptake, particularly booster doses, was low among hypertensive patients during the Omicron wave. Older age, female sex, and comorbidities were linked to lower vaccination rates, necessitating targeted interventions for this high-risk group.
Area of Science:
- Epidemiology
- Public Health
- Immunology
Background:
- The diminishing protective immunity from prior infection and mixed immunity highlights the importance of vaccination for sustained COVID-19 protection.
- Hypertensive individuals represent a vulnerable population susceptible to severe COVID-19 outcomes.
- Understanding vaccination patterns in this group is crucial for future public health strategies.
Purpose of the Study:
- To assess the vaccination status of hypertensive patients infected with the Omicron variant of COVID-19.
- To identify characteristics and risk factors associated with non-vaccination in this cohort.
- To inform targeted interventions for improving vaccine coverage in hypertensive populations.
Main Methods:
- A cohort of 4576 hypertensive patients with Omicron infection was analyzed.
- Data on vaccination status (at least one dose, booster dose) were collected.
- Multivariate logistic regression identified factors associated with vaccination status.
Main Results:
- 77.7% received at least one vaccine dose, and 45.0% received a booster dose.
- Male sex, younger age, and absence of comorbidities were associated with higher vaccination rates.
- Female sex, increasing age, and presence of diabetes, chronic pulmonary, kidney, or other cancers were associated with lower vaccination rates.
Conclusions:
- Vaccine coverage, especially for boosters, was suboptimal in hypertensive patients with Omicron infection.
- Factors such as female sex, advanced age, and comorbidities are linked to under-vaccination.
- Tailored public health initiatives are essential to enhance COVID-19 vaccination rates among diverse hypertensive patient groups.
Abstract:
The potential future burden of COVID-19 is determined by the level of susceptibility of the population to infection. The protective effect provided by those previously infected diminishes over several months, while individuals with mixed immunity have the highest degree and persistence of protection. This study aimed to clarify the vaccination status of COVID-19 patients with hypertension and to analyze the characteristics and risk factors of non-vaccinated patients to protect this vulnerable population in the future. The study ultimately enrolled 4576 hypertensive patients with Omicron infection from April 6, 2022, to May 15, 2022. Among them, 3556 patients (77.7%) had received at least one dose of vaccine, and 2058 patients (45.0%) received a booster dose. In the multivariate logistic analysis, male (OR 1.328, 95% CI 1.138-1.550, p < .001), age (60-69 years vs.18-49 years) (OR 0.348, 95% CI 0.270-0.448, p < .001), age (≥70 years vs.18-49 years) (OR 0.130, 95% CI 0.100-0.169, p < .001), diabetes mellitus (OR 0.553, 95% CI 0.463-0.661, p < .001), chronic pulmonary diseases (OR 0.474, 95% CI 0.260-0.863, p = .015), chronic kidney disease (OR 0.177, 95% CI 0.076-0.410, p < .001), and cancer (OR 0.225, 95% CI 0.094-0.535, p = .001) were associated with vaccinated status. The vaccine coverage rate, especially the booster vaccine, was low for hypertensive patients with Omicron infection. Females, increasing age, and coexisting chronic diseases were associated with more inadequate vaccine coverage in hypertensive COVID-19 patients. Targeted interventions are required to address the under-vaccination of diverse hypertensive populations.
More Related Videos
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension II: Pathophysiology
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Hypertension and Regulation of Blood Pressure

